JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A2602 Calpain Inhibitor I, ALLN
5 Citation

Target: Cathepsins|Calpains

Summary: Calpain I/II/ B/L inhibitor
A2577 Batimastat (BB-94)
17 Citation

Summary: MMP inhibitor

≥23.88 mg/mL
A4084 Vorinostat (SAHA, MK0683)
21 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
A4166 EPZ5676
2 Citation

Target: DOT1L

Summary: DOT1L inhibitor,potent and SAM competitive

≥28.15 mg/mL
A4099 Valproic acid sodium salt

Target: Histone Deacetylases (HDACs)

Summary: A class I HDAC inhibitor

≥8.35 mg/mL
A4152 BMS-911543

Target: JAK

Summary: JAK2 inhibitor,selective small molecule

≥43.3 mg/mL
A2614 Bortezomib (PS-341)
52 Citation

Target: Proteasome

Summary: proteasome inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL
A1909 BIX 01294
2 Citation

Target: G9a

Summary: G9a and GLP inhibitor

≥24.45 mg/mL
A1910 Bromodomain Inhibitor, (+)-JQ1
66 Citation

Target: Bromodomains

Summary: BET bromodomain inhibitor

≥22.85 mg/mL
A1913 RG 108
3 Citation

Target: DNA Methyltransferases

Summary: DNA methyltransferase inhibitor

insoluble in H2O; ≥16.7 mg/mL